Authors

• Stephen T. Oh (ORCID: https://orcid.org/0000-0002-8564-5400)
• Steffen Koschmieder (ORCID: https://orcid.org/0000-0002-1011-8171)
• Francesco Passamonti (ORCID: https://orcid.org/0000-0001-8068-5289)
• Moshe Talpaz (ORCID: https://orcid.org/0000-0003-3361-3981)
• Donal P. McLornan (ORCID: https://orcid.org/0000-0003-1224-091X)
• Aaron T. Gerds (ORCID: https://orcid.org/0000-0002-3422-1309)
• Yeow Tee Goh (ORCID: https://orcid.org/0000-0002-7069-0997)
• Ruben A. Mesa (ORCID: https://orcid.org/0000-0001-5880-7972)
• María Laura Fox (ORCID: https://orcid.org/0000-0002-0062-6607)
• Claire N. Harrison (ORCID: https://orcid.org/0000-0002-3212-920X)
• Andrew C. Perkins (ORCID: https://orcid.org/0000-0003-3644-7093)
• Francisco Jose Gonzalez Carreras (ORCID: https://orcid.org/0000-0002-3043-7495)
• Jeanne Palmer (ORCID: https://orcid.org/0000-0002-2185-1504)
• Lynda Foltz
• Catherine Ellis (ORCID: https://orcid.org/0009-0008-7635-7846)
• Sung‐Eun Lee (ORCID: https://orcid.org/0000-0002-9810-2050)
• Vikas Gupta
• Bryan Strouse
• Alessandro M. Vannucchi

Institutions

• Hebron University (PS)
• Atrium Health Wake Forest Baptist (US)
• Cleveland Clinic (US)
• University College London Hospitals NHS Foundation Trust (GB)
• University of British Columbia (CA)
• University of Toronto (CA)
• Guy's and St Thomas' NHS Foundation Trust (GB)
• Washington University in St. Louis (US)
• Singapore General Hospital (SG)
• University of Michigan (US)
• Age UK (GB)
• Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
• Integrated Oncology (United States) (US)
• GlaxoSmithKline (United States) (US)
• Michigan Center for Translational Pathology (US)
• Mayo Clinic Hospital (US)
• The Catholic University of Korea Seoul St. Mary's Hospital (KR)
• Alfred Health (AU)
• Wake Forest Baptist Comprehensive Cancer Center
• University of Florence (IT)
• University College London (GB)
• Monash University (AU)
• Catholic University of Korea (KR)
• RWTH Aachen University (DE)

Publication Details

Journal

Clinical Lymphoma Myeloma & Leukemia

Published

2024-10-16

DOI

https://doi.org/10.1016/j.clml.2024.10.001

Citations

4

Primary Topic

Myeloproliferative Neoplasms: Diagnosis and Treatment

Type

article

Field-Weighted Citation Impact

1.75

Funders

• GlaxoSmithKline